Description
About Us PatientIQ is the leading outcomes intelligence platform for healthcare â purpose-built to help health systems, specialty practices, medical device companies, and medical societies collect, analyze, and act on patient-reported outcomes data at scale. Our platform â ClinicalPRO, ResearchPRO, and DataPRO â powers clinical research, post-market surveillance, registry management, and value-based care programs across hundreds of provider organizations and some of the largest device manufacturers in the world. About The Role PatientIQ is hiring its first VP of Customer Growth â a revenue-generating commercial leader who will own net revenue retention, expansion ARR, and the strategic account program across our full customer base. This is not a traditional CS role. The VP Customer Growth carries expansion quota, builds a CS-as-revenue model, and leads a team that includes Customer Success-Enterprise, Outcomes Research & Registries, and Customer Success-Specialty Practice. The incoming leader will inherit a strong team, a clear structure, and a commercially ambitious mandate: grow NRR to 120%+ while protecting and expanding relationships with some of the most consequential health systems and specialty practices in the country. Role Responsibilities Own the full NRR and expansion ARR targets for PatientIQ â the primary commercial metric for this role Lead three teams: CS Enterprise (health systems, new strategic partners), CS Specialty Practice (specialty practices), and Outcomes Research & Registries (Provider, MedTech, Societies) Carry and manage personal expansion quota; build and administer CSM-level expansion incentive plans tied to ARR growth Own the Strategic Account Program for named accounts â executive relationship management, multi-year expansion planning, and EBR cadence Build the CS-as-revenue operating model: playbooks, tooling, metrics, and team structure that treats CS as a growth engine, not a cost center Partner with the VP Provider Sales in a commercial pod model â aligned coverage of Enterprise and Specialty accounts from sale through expansion
Apply Now
Posted 7/2/2026